RDDC RNA Splicer Precisely Predicts Splicing Effects of a Deep Intronic VUS
In genetic diagnostics, deep intronic variants are a significant challenge. Their distance from canonical splice sites makes their functional consequences difficult to predict, often leading to their classification as "Variants of Uncertain Significance" (VUS) under ACMG guidelines. A recent study of a family with recurrent fetal hydrops clearly demonstrates how advanced bioinformatics tools like the RDDC RNA Splicer provide critical in silico predictions for such VUS, guiding experimental validation and successfully elucidating a new pathogenic mechanism.
The Clinical Challenge: A VUS-Classified Deep Intronic Variant
In this study, a family with a history of three cases of fetal hydrops underwent Whole Exome Sequencing. Researchers identified a novel deep intronic variant in the RYR1 gene: c.538-33C>A. While RYR1 mutations are known to be associated with various skeletal muscle disorders, the pathogenicity of this specific variant was unknown and classified as a VUS. Determining whether this VUS was the cause of the fetal hydrops was the core challenge for the research team.
RDDC's Prediction and Experimental Validation
To assess the variant's function, the team used several bioinformatics tools, including the RDDC RNA Splicer. The RDDC analysis provided specific, testable hypotheses: it predicted the mutation could lead to "intron retention or exon skipping" effects.
This in silico prediction provided a clear direction for wet-lab experiments. The team proceeded with in vitro minigene splicing assays. The results were compelling: the variant indeed caused two aberrant splicing patterns: a complete deletion of exon 7 and a 31bp retention of intron 6. Both of these abnormal splices were predicted to cause frameshifts and premature stop codons, leading to truncated, non-functional proteins.
Crucially, this experimental result was highly consistent with the RDDC RNA Splicer's prediction. This discovery successfully upgraded the c.538-33C>A variant from "Uncertain Significance" to "Pathogenic," confirming it as the cause of fetal hydrops by disrupting mRNA splicing.
Case Implications: A Reliable Tool for Tackling VUS
This case strongly demonstrates that the RDDC RNA Splicer is a powerful and practical tool for researchers facing functionally unclassified deep intronic variants. It not only provides accurate predictions of splicing effects but also generates clear hypotheses and targets for functional experiments, helping scientists efficiently uncover the pathogenic mechanisms behind complex genetic variations.
Content Source and Disclaimer
This article is a compilation and interpretation of the scientific study cited below, intended to highlight the application of RDDC bioinformatics tools. All research data and conclusions belong to the original authors and publication.
Original Article:
Liu X, Chen S, Wu Q, et al. A novel homozygous intronic variant affecting splicing in the RYR1 gene contributes to fetal hydrops. Clinical Chimica Acta. 2023 Oct 15;550:117565.
Article Link:
https://pubmed.ncbi.nlm.nih.gov/39211906/
